دورية أكاديمية
[Precision medicine and immuno-radiotherapy].
| العنوان: | [Precision medicine and immuno-radiotherapy]. |
|---|---|
| عنوان ترانسليتريتد: | Médecine de précision et immunoradiothérapie. |
| المؤلفون: | Chargari C; Service de curiethérapie, département d'oncologie radiothérapie, Gustave Roussy Cancer Campus, Villejuif, France; Institut de recherche biomédicale des armées, Brétigny-sur-Orge, France; Radiothérapie moléculaire et thérapies innovantes, Inserm UMR1030, Gustave Roussy Cancer Campus, université Paris Saclay, Villejuif, France. Electronic address: cyrus.chargari@gustaveroussy.fr., Robert C; Service de curiethérapie, département d'oncologie radiothérapie, Gustave Roussy Cancer Campus, Villejuif, France; Radiothérapie moléculaire et thérapies innovantes, Inserm UMR1030, Gustave Roussy Cancer Campus, université Paris Saclay, Villejuif, France., Genestie C; Département d'anatomopathologie, Gustave Roussy Cancer Campus, Villejuif, France., Deutsch E; Service de curiethérapie, département d'oncologie radiothérapie, Gustave Roussy Cancer Campus, Villejuif, France; Radiothérapie moléculaire et thérapies innovantes, Inserm UMR1030, Gustave Roussy Cancer Campus, université Paris Saclay, Villejuif, France. |
| المصدر: | Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2021 Oct; Vol. 25 (6-7), pp. 570-575. Date of Electronic Publication: 2021 Aug 11. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | French |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: France NLM ID: 9711272 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1769-6658 (Electronic) Linking ISSN: 12783218 NLM ISO Abbreviation: Cancer Radiother Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Paris : Elsevier, c1997- |
| مواضيع طبية MeSH: | Immunotherapy/*methods , Neoplasms/*therapy , Precision Medicine/*methods , Radiotherapy/*methods, B7-H1 Antigen/metabolism ; Combined Modality Therapy/methods ; DNA Mismatch Repair ; Eosinophils ; Genome, Human ; Humans ; Interferon Type I/metabolism ; Interferon Type I/radiation effects ; Lymphocytes, Tumor-Infiltrating/immunology ; Mutation ; Neoplasms/genetics ; Neoplasms/immunology ; Programmed Cell Death 1 Receptor/metabolism ; Radiation Genomics |
| مستخلص: | Numerous clinical studies aim to integrate immunotherapy in radiotherapy oncology, either for generating abscopal responses in metastatic patients in combination with radiotherapy, or in the treatment of a locally advanced tumor. The search for biomarkers of response to treatment is a major axis in the development of these therapeutic combinations, to allow the early identification of patients who will benefit from the treatment, in the context of an increasingly personalized approach. We review some of the strategies that can be applied for personalization to combined radiotherapy and immunotherapy treatments. (Copyright © 2021. Published by Elsevier Masson SAS.) |
| فهرسة مساهمة: | Keywords: Biomarkers; Biomarqueurs; Immunotherapy; Immunothérapie; Oncologie radiothérapie; Radiation oncology; Radiotherapy; Radiothérapie |
| المشرفين على المادة: | 0 (B7-H1 Antigen) 0 (CD274 protein, human) 0 (Interferon Type I) 0 (PDCD1 protein, human) 0 (Programmed Cell Death 1 Receptor) |
| تواريخ الأحداث: | Date Created: 20210815 Date Completed: 20210930 Latest Revision: 20210930 |
| رمز التحديث: | 20221213 |
| DOI: | 10.1016/j.canrad.2021.06.032 |
| PMID: | 34391650 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1769-6658 |
|---|---|
| DOI: | 10.1016/j.canrad.2021.06.032 |